Sign Up Today and Learn More About Cleerly Stock
Invest in or calculate the value of your shares in Cleerly or other pre-IPO companies through EquityZen's platform.
About Cleerly Stock
Founded
2017
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
Cleerly is headquartered in New York, NY, and was founded in 2017. Notable investors include Fidelity Management and Research, Novartis, and T. Rowe Price.
Cleerly Press Mentions
Stay in the know about the latest news on Cleerly
Plaque levels on AI-enhanced CCT impart greater relative risk for women
bioworld • Apr 08, 2025
In the clinic for April 1, 2025
bioworld • Apr 02, 2025
Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25
biospace • Mar 27, 2025
AI in Healthcare: Key Innovations and 5 Companies to Watch in 2025
pharmiweb • Mar 11, 2025
Other news to note for March 4, 2025
bioworld • Mar 05, 2025
Investors in Cleerly
Discover investors in Cleerly stock and explore their portfolio companies
Cleerly Management
Leadership team at Cleerly
Chief Executive Officer
James Min
Chief Medical Officer
James Earls
Join now and verify your accreditation status to gain access to:
- Cleerly Current Valuation
- Cleerly Stock Price
- Cleerly Management
- Available deals in Cleerly and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cleerly Cap Table and Funding History by Share Class and Liquidity Preferences
- Cleerly Revenue and Financials
- Cleerly Highlights
- Cleerly Business Model
- Cleerly Risk Factors
- Cleerly Research Report from SACRA Research
Trading Cleerly Stock
How to invest in Cleerly stock?
Accredited investors can buy pre-IPO stock in companies like Cleerly through EquityZen funds. These investments are made available by existing Cleerly shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cleerly stock?
Shareholders can sell their Cleerly stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
